Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Inpatient data and early complications

From: Pelvic exenteration in gynecologic cancer: complications and oncological outcome

Hospitalisation stay (days) [Mean ± SD (range)] 22.9 ± 15.9 (7–72)
ICU stay [n (%)] 2.2 ± 1.5 (1–5)
Re- surgery [n (%)] 4 (17)
TPN [n (%)] 10 (43)
Patients with transfusion [n (%)] 11 (48)
Transfusion (Units) [Mean ± SD (range)] 1.96 ± 2.7 (1–10)
Circulatory event [n (%)]
 Thromboembolism 0 (0)
 Cardiovascular event 0 (0)
Urinary [n (%)]
 No 19 (83)
 Ureter leakage 2 (9)
 Urostomy complication 1 (4)
 Renal failure 3 (13)
Gastrointestinal [n (%)]
 Paralytic ileus 6 (26)
 Leakage 0 (0)
Wound [n (%)]
 No 15 (65)
 Dehiscence 7 (30)
 Infection 5 (22)
 Haematoma 1 (4)
 Flap necrosis 1 (4)
 Lymphorrea 1 (4)
Infectious [n (%)]
 No 17 (74)
 Abscess 2 (9)
 Fever and bacteremia 3 (13)
 Sepsis 1 (4)
Respiratory [n (%)]
 Infectious 0 (0)
 Respiratory insufficiency 1 (4)
Others [n (%)]
 Motor dysfunction 1 (4)
Clavien Dindo [Mean ± SD (range)]
Grade II 1.8 ± 1.6 (0–5)
Grade III 0.3 ± 0.5 (0–2)
Grade IV 0.1 ± 0.53 (0–1)
Grade V 0 ±  (0–0)
Patients with complication [n (%)] 5 (22)
Grade II 15 (65)
Grade III 5 (22)
Grade IV 2 (9)
Grade V 0 (0)
  1. ICU Intensive Care Unit, TPN total parenteral nutrition